{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_002374865.1:c.309G>A (p.G309D)",
          "cDNA Change": {
            "transcript": "NM_002374865.1",
            "ref": "G",
            "alt": "A",
            "position": "309"
          },
          "Protein Change": {
            "ref": "D",
            "alt": "R",
            "position": "309"
          },
          "Description in input context": "PINK1 G309D mutation."
        },
        {
          "HGVS": "NM_002374865.1:c.347T>C (p.L347P)",
          "cDNA Change": {
            "transcript": "NM_002374865.1",
            "ref": "T",
            "alt": "C",
            "position": "347"
          },
          "Protein Change": {
            "ref": "P",
            "alt": "L",
            "position": "347"
          },
          "Description in input context": "PINK1 L347P mutation."
        },
        {
          "HGVS": "NM_002374865.1:c.437G>A (p.W437D)",
          "cDNA Change": {
            "transcript": "NM_002374865.1",
            "ref": "G",
            "alt": "A",
            "position": "437"
          },
          "Protein Change": {
            "ref": "D",
            "alt": "R",
            "position": "437"
          },
          "Description in input context": "PINK1 W437D mutation."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease (PD)",
    "MONDO": "MONDO:0015463"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro and in vivo studies",
      "Material used": {
        "Material Source": "Cell lines (e.g., PC28)",
        "Material Name": "HEK293, PC28",
        "Description": "Cells were grown in vitro or used for in vivo studies."
      },
      "Readout type": "Quantitative measurement of cytochrome c release as an endpoint for apoptosis.",
      "Readout description": [
        {
          "Variant": "NM_002374865.1:c.309G>A (p.G309D)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Partial loss-of-function",
          "Result Description": "Cytokine release greater than 80% was considered normal, while less than 50% was classified as abnormal."
        },
        {
          "Variant": "NM_002374865.1:c.347T>C (p.L347P)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Partial loss-of-function",
          "Result Description": "Cytokine release greater than 80% was considered normal, while less than 50% was classified as abnormal."
        },
        {
          "Variant": "NM_002374865.1:c.437G>A (p.W437D)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Partial loss-of-function",
          "Result Description": "Cytokine release greater than 80% was considered normal, while less than 50% was classified as abnormal."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Three biological replicates were performed for in vitro studies.",
        "Description": "In vivo experiments also included three biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "Each sample was analyzed in triplicate on the Western blot machine.",
        "Description": "Repeatability and reproducibility were ensured through technical replicates."
      },
      "Basic positive control": {
        "Basic positive control": "Wild-type cDNA was used as a positive control.",
        "Description": "Used to confirm proper loading of probe."
      },
      "Basic negative control": {
        "Basic negative control": "Empty vector was used as a negative control.",
        "Description": "Ensured specificity in detection."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Two validation controls for pathogenic variants were included to confirm assay specificity and sensitivity.",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "One validation control for benign variants was included.",
        "Counts": "1"
      },
      "Statistical analysis method": "Not explicitly mentioned in the literature, but typically includes ANOVA or t-tests to compare means between groups.",
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cytokine release greater than 80% on day 7 was considered normal.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cytokine release less than 50% on day 7 was considered abnormal.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes (Western blot and cell viability assays are standard methods in molecular biology)"
      }
    }
  ]
}